Cargando…
Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease
BACKGROUND: Cardiovascular disease (CVD) is reported to be higher in elderly diabetics. Serum heart-type fatty acid binding protein (H-FABP) is a serum marker of myocardial ischemia. We aimed to investigate the association between serum H-FABP level and conventional cardiovascular risk factors, infl...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722006/ https://www.ncbi.nlm.nih.gov/pubmed/29255351 http://dx.doi.org/10.2147/CIA.S137247 |
_version_ | 1783284927880495104 |
---|---|
author | Beysel, Selvihan Kizilgul, Muhammed Ozbek, Mustafa Caliskan, Mustafa Kan, Seyfullah Apaydin, Mahmut Ozcelik, Ozgur Cakal, Erman |
author_facet | Beysel, Selvihan Kizilgul, Muhammed Ozbek, Mustafa Caliskan, Mustafa Kan, Seyfullah Apaydin, Mahmut Ozcelik, Ozgur Cakal, Erman |
author_sort | Beysel, Selvihan |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease (CVD) is reported to be higher in elderly diabetics. Serum heart-type fatty acid binding protein (H-FABP) is a serum marker of myocardial ischemia. We aimed to investigate the association between serum H-FABP level and conventional cardiovascular risk factors, inflammatory markers and subclinical atherosclerosis in elderly diabetics without overt CVD. PATIENTS AND METHODS: A total of 50 elderly diabetic patients without overt CVD and 30 age-, sex- and body mass index (BMI)-matched healthy controls were enrolled. Anthropometric and biochemical parameters, serum H-FABP, high-sensitivity C-reactive protein (hs-CRP), fibrinogen and carotid intima-media thickness (CIMT) were measured. Logistic regression analyses (adjustments for age, sex, hypertension, smoking, diabetes, BMI, blood pressure, lipid, blood glucose, hemoglobin A1c, hs-CRP and fibrinogen) were performed to evaluate the association between H-FABP and cardiovascular risk factors and atherosclerosis indices. RESULTS: Serum fibrinogen (421.50±85.52 mg/dL vs 319.17±30.77 mg/dL, p=0.023), CIMT (0.70±0.12 mm vs 0.59±0.06 mm, p<0.001) and hs-CRP (5.72±4.50 mg/dL vs 1.60±0.72 mg/dL, p<0.001) were significantly higher in diabetic patients than controls. The mean serum H-FABP level did not differ between groups (1571.79±604.60 ng/mL vs 1500.25±463.35 ng/mL, p=0.905). H-FABP was positively correlated with fibrinogen (r(2)=0.473, p<0.001), hs-CRP (r(2)=0.323, p=0.003) and CIMT (r(2)=0.467, p<0.001). After full adjustments, the serum H-FABP level was independently associated with an increase in the fibrinogen level (odds ratio [OR] =4.21, 95% confidence level [CI] =1.49–11.90). CONCLUSION: Serum H-FABP was similar in the elderly diabetic patients without known CVD when compared with the nondiabetic control group. H-FABP does not possess a high diagnostic value as a cardiovascular marker when used alone; however, it may add supplementary information in patients with a high fibrinogen level. |
format | Online Article Text |
id | pubmed-5722006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57220062017-12-18 Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease Beysel, Selvihan Kizilgul, Muhammed Ozbek, Mustafa Caliskan, Mustafa Kan, Seyfullah Apaydin, Mahmut Ozcelik, Ozgur Cakal, Erman Clin Interv Aging Original Research BACKGROUND: Cardiovascular disease (CVD) is reported to be higher in elderly diabetics. Serum heart-type fatty acid binding protein (H-FABP) is a serum marker of myocardial ischemia. We aimed to investigate the association between serum H-FABP level and conventional cardiovascular risk factors, inflammatory markers and subclinical atherosclerosis in elderly diabetics without overt CVD. PATIENTS AND METHODS: A total of 50 elderly diabetic patients without overt CVD and 30 age-, sex- and body mass index (BMI)-matched healthy controls were enrolled. Anthropometric and biochemical parameters, serum H-FABP, high-sensitivity C-reactive protein (hs-CRP), fibrinogen and carotid intima-media thickness (CIMT) were measured. Logistic regression analyses (adjustments for age, sex, hypertension, smoking, diabetes, BMI, blood pressure, lipid, blood glucose, hemoglobin A1c, hs-CRP and fibrinogen) were performed to evaluate the association between H-FABP and cardiovascular risk factors and atherosclerosis indices. RESULTS: Serum fibrinogen (421.50±85.52 mg/dL vs 319.17±30.77 mg/dL, p=0.023), CIMT (0.70±0.12 mm vs 0.59±0.06 mm, p<0.001) and hs-CRP (5.72±4.50 mg/dL vs 1.60±0.72 mg/dL, p<0.001) were significantly higher in diabetic patients than controls. The mean serum H-FABP level did not differ between groups (1571.79±604.60 ng/mL vs 1500.25±463.35 ng/mL, p=0.905). H-FABP was positively correlated with fibrinogen (r(2)=0.473, p<0.001), hs-CRP (r(2)=0.323, p=0.003) and CIMT (r(2)=0.467, p<0.001). After full adjustments, the serum H-FABP level was independently associated with an increase in the fibrinogen level (odds ratio [OR] =4.21, 95% confidence level [CI] =1.49–11.90). CONCLUSION: Serum H-FABP was similar in the elderly diabetic patients without known CVD when compared with the nondiabetic control group. H-FABP does not possess a high diagnostic value as a cardiovascular marker when used alone; however, it may add supplementary information in patients with a high fibrinogen level. Dove Medical Press 2017-12-05 /pmc/articles/PMC5722006/ /pubmed/29255351 http://dx.doi.org/10.2147/CIA.S137247 Text en © 2017 Beysel et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Beysel, Selvihan Kizilgul, Muhammed Ozbek, Mustafa Caliskan, Mustafa Kan, Seyfullah Apaydin, Mahmut Ozcelik, Ozgur Cakal, Erman Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
title | Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
title_full | Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
title_fullStr | Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
title_full_unstemmed | Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
title_short | Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
title_sort | heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722006/ https://www.ncbi.nlm.nih.gov/pubmed/29255351 http://dx.doi.org/10.2147/CIA.S137247 |
work_keys_str_mv | AT beyselselvihan hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease AT kizilgulmuhammed hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease AT ozbekmustafa hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease AT caliskanmustafa hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease AT kanseyfullah hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease AT apaydinmahmut hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease AT ozcelikozgur hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease AT cakalerman hearttypefattyacidbindingproteinlevelsinelderlydiabeticswithoutknowncardiovasculardisease |